No abstract available
Keywords:
ABT-199; BCL2; CXCR4; Ibrutinib; Waldenström macroglobulinemia.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
-
Apoptosis / drug effects
-
Apoptosis Regulatory Proteins / genetics*
-
Apoptosis Regulatory Proteins / metabolism
-
Bcl-2-Like Protein 11
-
Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
-
Drug Synergism
-
Humans
-
Membrane Proteins / genetics*
-
Membrane Proteins / metabolism
-
Piperidines
-
Proto-Oncogene Proteins / genetics*
-
Proto-Oncogene Proteins / metabolism
-
Purines / administration & dosage
-
Purines / pharmacology*
-
Pyrazoles / administration & dosage
-
Pyrazoles / pharmacology*
-
Pyrimidines / administration & dosage
-
Pyrimidines / pharmacology*
-
Quinazolinones / administration & dosage
-
Quinazolinones / pharmacology*
-
Receptors, CXCR4 / genetics*
-
Receptors, CXCR4 / metabolism
-
Sulfonamides / administration & dosage
-
Sulfonamides / pharmacology*
-
Waldenstrom Macroglobulinemia / drug therapy*
-
Waldenstrom Macroglobulinemia / genetics
-
Waldenstrom Macroglobulinemia / metabolism
-
Waldenstrom Macroglobulinemia / pathology
Substances
-
Apoptosis Regulatory Proteins
-
BCL2L11 protein, human
-
Bcl-2-Like Protein 11
-
Bridged Bicyclo Compounds, Heterocyclic
-
CXCR4 protein, human
-
Membrane Proteins
-
Piperidines
-
Proto-Oncogene Proteins
-
Purines
-
Pyrazoles
-
Pyrimidines
-
Quinazolinones
-
Receptors, CXCR4
-
Sulfonamides
-
ibrutinib
-
Adenine
-
venetoclax
-
idelalisib